Re: [tips] Correlation/ Causation?

[Jonathan Mueller]

Nice example.  As a reminder, I have collected a large number of such headlines 
and related activities at
 
http://jfmueller.faculty.noctrl.edu/100/correlation_or_causation.htm
 
Jon


 
 
===
Jon Mueller
Professor of Psychology
North Central College
30 N. Brainard St.
Naperville, IL 60540
voice: (630)-637-5329
fax: (630)-637-5121
jfmuel...@noctrl.edu
http://jonathan.mueller.faculty.noctrl.edu
>>> "Joan Warmbold"  1/7/2013 4:56 PM >>>
http://health.usnews.com/health-news/news/articles/2012/12/20/early-language-skills-reduce-preschool-tantrums-study-finds

Another interesting example of a correlation being interpreted as
causation.  Yes, there is certain logical reasons for the conclusion
proposed but parenting styles and temperament are two logical intermediary
factors relating to language skills and tantrums.

Joan
jwarm...@oakton.edu





---
You are currently subscribed to tips as: jfmuel...@noctrl.edu.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13269.01f6211e00cc8f00a7b68e8e24b1b4d6&n=T&l=tips&o=22744
or send a blank email to 
leave-22744-13269.01f6211e00cc8f00a7b68e8e24b1b...@fsulist.frostburg.edu


---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22754
or send a blank email to 
leave-22754-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

[tips] Cue-dependent memory : Newtown/ Scotland

[michael sylvester]

Students of the former Sandy Hook school of Newtown
now have a new remodelled school to attend.The new school
is engineered to replicate the exact structural conditions
of the former classrooms,the rationale being that similarity
of environmental conditions transferred would decrease
stress on students.It seems to me that the opposite could
also be true-stress cues in one condition can also trigger
stress responses in similar conditions.After all the whole
idea of post traumatic stress is that cues can be generalized
and evoke the same social,cognitive,physiological stressful
parameters.
However there was a similar incident of a school shooting
in Scotland years past.The Brits however tightened gun control
after that,but did not see the necessitty to demolish
or transfer the school children to another school.
Now some may say that these were only first and second
graders so the impact may be minimal.Well let us not
forget the iceberg.
Michael J Sylvester,PhD
Daytona Beach,Florida 

---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22756
or send a blank email to 
leave-22756-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

[tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Mike Palij]

The journal "Nature Medicine" has a disturbing article on a legal decision
concerning whether a Food and Drug Administration (FDA) approved drug
can be used or advertised for "off-label" use.  The FDA typically requires
that a drug company demonstrate evidence that a drug is effective in the
treatment of a condition and, if shown to be effective, the drug can then be
marketed for treatment of this disease/disorder.  However, physicians
sometimes (often?) will use a drug shown to be effective for one condition
for another condition for which it has not been researched, a practice 
called

"off-label" use.  Physicians can take any FDA approved drug and use it
in an off-label manner for a condition that they and their patients are 
willing
to treat even though there is no research evidence that such use is 
effective.


It should not come as a big surprise that off-label drug use is a widespread
practice among physicians.  However, according to  the FDA such use is not
legal but it usually prosecutes cases where significant marketing is 
involved..

The FDA will prosecute individuals and companies that promote off-label
use of its approved drug, especially in advertising, and this is the heart 
of

our story.  Quoting from the article:

|In a 2-to-1 decision, the judges stated that banning off-label marketing
|violated the representative's freedom of speech. This ruling is a mistake,
|as it upholds the freedom of speech of people with a vested interest in
|promoting a product without considering the risk this represents for 
patients.

|By opening the door to off-label drug promotion by people with commercial
|motivations, the court decision undermines the authority of the FDA and the
|process whereby new drugs are approved. Indeed, the dissenting judge,
|Judge Debra Ann Livingston, argued that if pharma companies can promote
|FDA-approved drugs for nonapproved uses, "they would have little incentive
|to seek FDA approval for those uses." In other words, why bother with a
|long and expensive clinical trial if one can just market a drug without it?
|
|The court found that, as long as the information that pharma sales 
representatives
|give to doctors is true, the FDCA cannot curtail their freedom of speech. 
The

|decision therefore changes the burden of proof for prosecution of companies
|for misbranding a drug in accordance with the FDCA. It will no longer be
|enough to spot off-label marketing to cry foul; instead, it will be 
necessary to

|show that the information presented is false.

Here is the critical part:

|But, considering that there are essentially no clinical efficacy data for 
using

|Xyrem to treat Caronia's broad list of diseases, the ruling did not seem to
|take into account whether his statements were true or not. For the purpose
|of the decision, they seem to have been considered as true enough.
http://www.nature.com/nm/journal/v19/n1/full/nm.3061.html?WT.ec_id=NM-201301

The original case involved a physician's treatment of several conditions
(e.g., fibromyalgia, chronic pain, Parkinson's disease) with the drug Xyrem
(a drug FDA approved to treat catalepsy and narcolepsy; it is also known
as GHB and has been used as a date-rape drug).  The judges essentially
said that banning off-label marketing of a drug was a violation of a 
person's
freedom of speech.  The issue is whether any claim that the drug is 
effective for

conditions that it was not originally FDA tested for, should be considered
a "true" statement because there is no evidence that it is an appropriate 
treatment
for the condition.  Yet it appears that the judges did not appreciate this 
point

and/or considered the truthfulness of the statement as not as important as a
person or drug company's "right" to claim that the drug can be used for 
almost

any condition.

Something to think about.

-Mike Palij
New York University
m...@nyu.edu


---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22757
or send a blank email to 
leave-22757-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

[tips] faculty position, Clinical Psychology

[David Kreiner]

*ASSISTANT PROFESSOR IN PSYCHOLOGY (998583)*. The Department of
Psychological Science at the University of Central Missouri (www.ucmo.edu
/psychology) seeks to fill a tenure-track assistant professor position in
Psychology.  The doctoral degree must be completed by time of appointment.
Position begins August, 2013. Successful candidates will provide evidence
of excellence in teaching, the ability and interest to involve
undergraduate and master’s level graduate students in their research as
well as to foster student career/professional development.



Must have doctorate in Clinical Psychology from an APA approved program and
have completed an APA approved internship. Expected to obtain licensure
within three years of appointment or have Missouri licensure at the time of
appointment. Applicant must be able to teach Personality (undergraduate and
graduate) and Adult Psychopathology (graduate).  Ability to teach one or
more of the following courses preferred: Intelligence Testing (adult and
child), Forensic Psychology, Abnormal Psychology.



In addition to the courses specific to this position, the ability to teach
one or more of the following undergraduate courses: General Psychology,
Research Design & Analysis I and II, Psychological Measurement, Systems of
Psychology (capstone course) is preferred as well as training and
experience in program evaluation and assessment.



Salary is competitive. Standard teaching load is 12 credit hours per
semester; opportunities to teach during the summer are available.
Excellence in teaching, productivity in research, and service to the
department, college, and university are expected for promotion and tenure.



*To apply:* Candidates must complete an on-line faculty profile found at
https://jobs.ucmo.edu and apply to position #998583.

Attach to the faculty profile a letter of application, current curriculum
vitae, black and white copies of transcripts showing all degrees completed
and documentation of teaching effectiveness. Please list on the faculty
profile the names, phone numbers and e-mail addresses for three
professional references.  If contacted for an interview, three letters of
recommendation will be requested.

*Review of completed applications begins February 1, 2013 and continues
until filled.*

For information about the on-line application process contact Human
Resources at j...@ucmo.edu or (660) 543-4255. The University of Central
Missouri is an AA/EEO/ADA employer.
UCM requires that all faculty applicants for this position complete the
on-line faculty profile and submit to the appropriate position for
consideration at jobs.ucmo.edu. All documents requested for this position
must also be attached to the faculty profile at the time of application.
Only completed online faculty profiles with attached documents will be
accepted for this position.

-- 
David Kreiner
Professor and Chair
Department of Psychological Science 
University of Central Missouri 
krei...@ucmo.edu

Treasurer, Society for the Teaching of
Psychology(APA Division 2)

---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22758
or send a blank email to 
leave-22758-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

RE: [tips] 4 Copy Editors Killed In Ongoing AP Style, Chicago Manual Gang Violence | The Onion - America's Finest News Source

[Marc Carter]

This has in large measure been the message that I give my students.  I'm not an 
APA maniac; copy editors are (or should be).  I would rather my students spend 
their energy on writing good papers, and as long as they do the important 
things (references need to be accurate, citations need to match references, 
information is in the right places, like that), I'm not going to spend a lot of 
my time on APA format.  I stress that there's a reason we do things the way we 
do (so that we can find things, so that we give proper attribution, etc.), but 
more important to me is that they learn to use good thinking and the literature 
to justify their hypotheses, they learn how a paper is put together, and that 
they understand why these things are important: reading well-written and 
well-organized papers is hard enough work.

m

PS  True story: in grad school we helped my advisor review a submission to 
Psych Science.  It was so (to borrow Scott's term) egregiously bad that in his 
(rejection) letter to the authors, Bill Estes wrote, "APS is not in the 
business of teaching APA format."  Ouch.

--
Marc Carter, PhD
Associate Professor of Psychology
Chair, Department of Behavioral and Health Sciences
College of Arts & Sciences
Baker University
--


> -Original Message-
> From: Lilienfeld, Scott O [mailto:slil...@emory.edu]
> Sent: Monday, January 07, 2013 8:14 PM
> To: Teaching in the Psychological Sciences (TIPS)
> Subject: [tips] 4 Copy Editors Killed In Ongoing AP Style, Chicago
> Manual Gang Violence | The Onion - America's Finest News Source
>
> I'm currently Associate Editor for an APA journal (Journal of Abnormal
> Psychology), and I probably shouldn't say this, but
>
> The minutae of APA style just aren't considered all that important when
> evaluating manuscripts, as copy-editors will take care of most of the
> details. Unless APA style violations in manuscripts are pretty
> egregious, reviewers rarely make a big deal about them.  Have served on
> the editorial boards of three other APA journals, my impressions there
> haven't been much different.
>
> Scott
>
>
> 
> From: Christopher Green [chri...@yorku.ca]
> Sent: Monday, January 07, 2013 5:39 PM
> To: Teaching in the Psychological Sciences (TIPS)
> Subject: [tips] 4 Copy Editors Killed In Ongoing AP Style, Chicago
> Manual Gang Violence | The Onion - America's Finest News Source
>
> I am perennially fascinated/horrified by the interest questions
> pertaining to APA style seem to generate. They just seem to me to be of
> about the same level of scholarly import as are, say, fights over
> whether the toilet paper should go over or under the roll.
>
> Sure, students need to be familiar with stylistic issues, but the
> details of any stylistic prescription rank so far below, well, just
> about everything else, from an intellectual perspective... The level of
> drill and perfection required by some astonishes me. (Full disclosure:
> I was once an APA style maven, but then I started writing for journals
> that required other styles, and I gradually realized what a wasteful
> and arbitrary matter most of it is.)
>
> I think this Onion piece puts things nicely in perspective (and notice
> that APA isn't even a "player").
>
> http://www.theonion.com/articles/4-copy-editors-killed-in-ongoing-ap-
> style-chicago,30806/
>
> Discussion? Retribution?
>
> Chris
> -
> Christopher D. Green
> Department of Psychology
> York University
> Toronto, ON M6C 1G4
> Canada
>
> chri...@yorku.ca
> ---
> You are currently subscribed to tips as: slil...@emory.edu.
> To unsubscribe click here:
> http://fsulist.frostburg.edu/u?id=13509.d0999cebc8f4ed4eb54d5317367e9b2
> f&n=T&l=tips&o=22742
> or send a blank email to leave-22742-
> 13509.d0999cebc8f4ed4eb54d5317367e9...@fsulist.frostburg.edu
>
> 
>
> This e-mail message (including any attachments) is for the sole use of
> the intended recipient(s) and may contain confidential and privileged
> information. If the reader of this message is not the intended
> recipient, you are hereby notified that any dissemination, distribution
> or copying of this message (including any attachments) is strictly
> prohibited.
>
> If you have received this message in error, please contact the sender
> by reply e-mail message and destroy all copies of the original message
> (including attachments).
>
> ---
> You are currently subscribed to tips as: marc.car...@bakeru.edu.
> To unsubscribe click here:
> http://fsulist.frostburg.edu/u?id=13029.76c7c563b32ad9d8d09c72a2d17c90e
> 1&n=T&l=tips&o=22746
> or send a blank email to leave-22746-
> 13029.76c7c563b32ad9d8d09c72a2d17c9...@fsulist.frostburg.edu

The information contained in this e-mail and any attachments thereto ("e-mail") 
is sent by Baker University ("BU") and is intended to be confidential and for 
the use of only the individual or entity named above. The information may be 
protected by federal and state pr

RE: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Horton, Joseph J.]

I am not particularly disturbed by this ruling depending upon just what claims 
are being made. If it is clear the claim is based on a collection of anecdotes 
rather than empirical study informing physicians that others have found a drug 
useful seems fine. I say this as one who regularly takes a drug for off label 
use. It is a generic drug and has been for a very long time. Thus it costs very 
little. No one would invest the time and money to conduct a clinical trial for 
my issue. Yet the drug has dramatically improved my quality of life. Were the 
FDA to take away my physician's ability to prescribe it for me, I would be 
quite disappointed.

Joe

Joseph J. Horton, Ph. D.
Box 3077
Grove City College
Grove City, PA 16127

724-458-2004
jjhor...@gcc.edu

In God we trust. All others must bring data.

-Original Message-
From: Mike Palij [mailto:m...@nyu.edu] 
Sent: Tuesday, January 08, 2013 10:53 AM
To: Teaching in the Psychological Sciences (TIPS)
Cc: Michael Palij
Subject: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

The journal "Nature Medicine" has a disturbing article on a legal decision
concerning whether a Food and Drug Administration (FDA) approved drug
can be used or advertised for "off-label" use.  The FDA typically requires
that a drug company demonstrate evidence that a drug is effective in the
treatment of a condition and, if shown to be effective, the drug can then be
marketed for treatment of this disease/disorder.  However, physicians
sometimes (often?) will use a drug shown to be effective for one condition
for another condition for which it has not been researched, a practice 
called
"off-label" use.  Physicians can take any FDA approved drug and use it
in an off-label manner for a condition that they and their patients are 
willing
to treat even though there is no research evidence that such use is 
effective.

It should not come as a big surprise that off-label drug use is a widespread
practice among physicians.  However, according to  the FDA such use is not
legal but it usually prosecutes cases where significant marketing is 
involved..
The FDA will prosecute individuals and companies that promote off-label
use of its approved drug, especially in advertising, and this is the heart 
of
our story.  Quoting from the article:

|In a 2-to-1 decision, the judges stated that banning off-label marketing
|violated the representative's freedom of speech. This ruling is a mistake,
|as it upholds the freedom of speech of people with a vested interest in
|promoting a product without considering the risk this represents for 
patients.
|By opening the door to off-label drug promotion by people with commercial
|motivations, the court decision undermines the authority of the FDA and the
|process whereby new drugs are approved. Indeed, the dissenting judge,
|Judge Debra Ann Livingston, argued that if pharma companies can promote
|FDA-approved drugs for nonapproved uses, "they would have little incentive
|to seek FDA approval for those uses." In other words, why bother with a
|long and expensive clinical trial if one can just market a drug without it?
|
|The court found that, as long as the information that pharma sales 
representatives
|give to doctors is true, the FDCA cannot curtail their freedom of speech. 
The
|decision therefore changes the burden of proof for prosecution of companies
|for misbranding a drug in accordance with the FDCA. It will no longer be
|enough to spot off-label marketing to cry foul; instead, it will be 
necessary to
|show that the information presented is false.

Here is the critical part:

|But, considering that there are essentially no clinical efficacy data for 
using
|Xyrem to treat Caronia's broad list of diseases, the ruling did not seem to
|take into account whether his statements were true or not. For the purpose
|of the decision, they seem to have been considered as true enough.
http://www.nature.com/nm/journal/v19/n1/full/nm.3061.html?WT.ec_id=NM-201301

The original case involved a physician's treatment of several conditions
(e.g., fibromyalgia, chronic pain, Parkinson's disease) with the drug Xyrem
(a drug FDA approved to treat catalepsy and narcolepsy; it is also known
as GHB and has been used as a date-rape drug).  The judges essentially
said that banning off-label marketing of a drug was a violation of a 
person's
freedom of speech.  The issue is whether any claim that the drug is 
effective for
conditions that it was not originally FDA tested for, should be considered
a "true" statement because there is no evidence that it is an appropriate 
treatment
for the condition.  Yet it appears that the judges did not appreciate this 
point
and/or considered the truthfulness of the statement as not as important as a
person or drug company's "right" to claim that the drug can be used for 
almost
any condition.

Something to think about.

-Mike Palij
New York University
m...@nyu.edu


---
You are currently subscribed to tips as: jjhor...

RE: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Mike Palij]

On Tue, 08 Jan 2013 08:59:25 -0800, Joseph J. Horton wrote:
I am not particularly disturbed by this ruling depending upon just what 
claims
are being made. If it is clear the claim is based on a collection of 
anecdotes
rather than empirical study informing physicians that others have found a 
drug

useful seems fine.


I suggest reading the following blog entry from a legal firm that maintains
the blog as a source of information on legal issues involving the FDA:
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2012/12/a-deep-dive-into-the-second-circuits-caronia-decision-potential-next-steps-and-potential-enforcement.html


I say this as one who regularly takes a drug for off label use.


I am not sure how this is relevant since mere personal experiences do not
constitute data, only anecdote (at best a case study if done systematically
but case studies are not scientific studies).  That being said, I too have
had conditions where there was no established treatment and have received
numerous drugs off-label, none of which worked (you don't know how
much I hoped for a good placebo effect).  A major problem with off-label
drug treatment are the side-effects which can be significant.  Sometimes
one thinks one is taking a step forward but winds up taking two steps back.


It is a generic drug and has been for a very long time. Thus it costs very
little. No one would invest the time and money to conduct a clinical trial 
for
my issue. Yet the drug has dramatically improved my quality of life. Were 
the

FDA to take away my physician's ability to prescribe it for me, I would be
quite disappointed.


With all sincerity, I am glad that the drug has done you good but I hope you
realize that if it is being used off-label: (a) there is no empirical 
research evidence
that the drug is the cause of the improvement (that is one of the major 
problems

with using a drug in an off-label manner though there may be various crappy
"open label" studies -- studies where participants and researchers know who
is receiving the drug, possibly with no placebo control) and (b) even if the
"Caronia case" goes in favor of the FDA on appeal, your doctor can still 
treat
you with the off label drug because the FDA's focus is on the marketing of 
the

drug.

Below I quote from the legal blog I cite above but I give warning that the 
quote

is long.  It does, however, provide much significant context:

NOTE: the FDA prosecutes off label marketing as a violation of
interstate commerce law; see the blog for details
|On November 30, 2009, a jury found Alfred Caronia guilty of misdemeanor
|conspiracy to introduce misbranded drugs into interstate commerce.  His
|conviction was based on off-label statements he made while employed
|as a pharmaceutical sales representative for Orphan Medical, Inc. 
("Orphan").

|Specifically, Caronia verbally promoted the drug Xyrem, a central nervous
|system depressant approved only for the treatment of certain categories
|of narcolepsy patients, to treat a variety of other conditions including 
insomnia,

|fibromyalgia, and Parkinson's.  He also promoted Xyrem for use in an
|unapproved patient population - individuals under the age of 16.
|
|The government began its investigation of Orphan in 2005, when former
|Orphan saleswoman Shelley Lauterbach filed a qui tam suit against the
|company.  During the course of the investigation, Caronia was recorded
|on two occasions discussing off-label uses of Xyrem.  On both occasions,
|Caronia was recorded speaking alongside Dr. Peter Gleason, a doctor
|that Caronia had engaged to participate in "speaker programs" intended
|to educate other physicians about Xyrem.  Caronia and Dr. Gleason
|discussed off-label uses for Xyrem with Dr. Jeffrey Charo, an undercover
|informant for the government.  In 2006, the government filed charges 
against

|Orphan, Dr. Gleason, Caronia, as well as David Tucker (a former Orphan
|sales manager) for conspiring to promote Xyrem for off-label uses, and
|thereby introduce a misbranded drug into interstate commerce.
|
|In March 2007, David Tucker pleaded guilty to a single felony misbranding
|charge.  In July 2007, Orphan pleaded guilty to felony charges, and its
|parent company, Jazz Pharmaceuticals, Inc., agreed to pay $20 million and
|enter into a Corporate Integrity Agreement to resolve both criminal and 
civil
|charges.  In August 2008, Dr. Gleason also pleaded guilty to criminal 
misbranding

|charges.
|
|Caronia, however, did not plead guilty and filed a motion to dismiss his 
case

|based inter alia on First Amendment grounds.  The District Court denied his
|motion, but noted that the allegations against Caronia included First
|Amendment-protected speech.  Nevertheless, the District Court concluded
|that the government's interpretation of the FDCA was constitutional under 
the

|commercial speech doctrine because it did not limit speech more than was
|necessary to achieve the government' objectives.  On appeal of Caronia's
|criminal 

Re: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Dr. Bob Wildblood]

Mike Palij wrote in part:

.Yet it appears that the judges did not appreciate
this >point>and/or considered the truthfulness of
the statement as not as important as a>person or
drug company's "right" to claim that the drug can
be used for >almost>any condition.>>Something to
think about.>>-

It sounds like the days of the con man selling
potions as they did in the "old days" is back with
us today.

---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22765
or send a blank email to 
leave-22765-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

[tips] BREAKING NEWS: Professors less stressful

[michael sylvester]

CNN is reporting that the least stressful job is that of a University professor 
and next is a seamstress.
I am not sure if this applies to the department chairperson.
  michael
---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22769
or send a blank email to 
leave-22769-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

RE: [tips] BREAKING NEWS: Professors less stressful

[José Ferreira Alves]

I can’t believe in that!!

Seems to me that we are within the most stressful and challenging jobs,
although also with good rewards

Jose

 

 

De: michael sylvester [mailto:msylves...@copper.net] 
Enviada: terça-feira, 8 de Janeiro de 2013 20:54
Para: Teaching in the Psychological Sciences (TIPS)
Assunto: [tips] BREAKING NEWS: Professors less stressful

 

 

 

 

 

 

 

CNN is reporting that the least stressful job is that of a University
professor and next is a seamstress.

I am not sure if this applies to the department chairperson.

michael

 

---

You are currently subscribed to tips as: al...@psi.uminho.pt.

To unsubscribe click here:
http://fsulist.frostburg.edu/u?id=13079.37464550bba7c9b4601a21fd9decb43c
 &n=T&l=tips&o=22769

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to
leave-22769-13079.37464550bba7c9b4601a21fd9decb...@fsulist.frostburg.edu

 

 

 

 


---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22770
or send a blank email to 
leave-22770-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

RE: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Horton, Joseph J.]

Mike my point is that there is potential harm when the FDA limits available 
treatments. Unless there is fraud involved, I am all for open communication 
between pharmaceutical companies, physicians and their patients.

I certainly appreciate the role of well-done clinical trials. (Note my 
signature file.) In the case of the drug I take, the patent protection expired 
decades ago. No clinical trials will be done. The potential side effects are 
well known. I am probably in more danger from taking low dose aspirin daily. I 
have to make decisions with less than perfect information every day. I support 
letting information freely flow so people can evaluate the evidence and make 
the most informed decisions possible.

Have a lovely evening,
Joe

Joseph J. Horton, Ph. D.
Box 3077
Grove City College
Grove City, PA 16127

724-458-2004
jjhor...@gcc.edu

In God we trust. All others must bring data.

-Original Message-
From: Mike Palij [mailto:m...@nyu.edu] 
Sent: Tuesday, January 08, 2013 1:33 PM
To: Teaching in the Psychological Sciences (TIPS)
Cc: Michael Palij
Subject: RE: [tips] Failure of Critical Thinking: When Advertising Trumps 
"Truth"

On Tue, 08 Jan 2013 08:59:25 -0800, Joseph J. Horton wrote:
>I am not particularly disturbed by this ruling depending upon just what 
>claims
>are being made. If it is clear the claim is based on a collection of 
>anecdotes
>rather than empirical study informing physicians that others have found a 
>drug
>useful seems fine.

I suggest reading the following blog entry from a legal firm that maintains
the blog as a source of information on legal issues involving the FDA:
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2012/12/a-deep-dive-into-the-second-circuits-caronia-decision-potential-next-steps-and-potential-enforcement.html

>I say this as one who regularly takes a drug for off label use.

I am not sure how this is relevant since mere personal experiences do not
constitute data, only anecdote (at best a case study if done systematically
but case studies are not scientific studies).  That being said, I too have
had conditions where there was no established treatment and have received
numerous drugs off-label, none of which worked (you don't know how
much I hoped for a good placebo effect).  A major problem with off-label
drug treatment are the side-effects which can be significant.  Sometimes
one thinks one is taking a step forward but winds up taking two steps back.

>It is a generic drug and has been for a very long time. Thus it costs very
>little. No one would invest the time and money to conduct a clinical trial 
>for
>my issue. Yet the drug has dramatically improved my quality of life. Were 
>the
>FDA to take away my physician's ability to prescribe it for me, I would be
>quite disappointed.

With all sincerity, I am glad that the drug has done you good but I hope you
realize that if it is being used off-label: (a) there is no empirical 
research evidence
that the drug is the cause of the improvement (that is one of the major 
problems
with using a drug in an off-label manner though there may be various crappy
"open label" studies -- studies where participants and researchers know who
is receiving the drug, possibly with no placebo control) and (b) even if the
"Caronia case" goes in favor of the FDA on appeal, your doctor can still 
treat
you with the off label drug because the FDA's focus is on the marketing of 
the
drug.

Below I quote from the legal blog I cite above but I give warning that the 
quote
is long.  It does, however, provide much significant context:

NOTE: the FDA prosecutes off label marketing as a violation of
interstate commerce law; see the blog for details
|On November 30, 2009, a jury found Alfred Caronia guilty of misdemeanor
|conspiracy to introduce misbranded drugs into interstate commerce.  His
|conviction was based on off-label statements he made while employed
|as a pharmaceutical sales representative for Orphan Medical, Inc. 
 ("Orphan").
|Specifically, Caronia verbally promoted the drug Xyrem, a central nervous
|system depressant approved only for the treatment of certain categories
|of narcolepsy patients, to treat a variety of other conditions including 
insomnia,
|fibromyalgia, and Parkinson's.  He also promoted Xyrem for use in an
|unapproved patient population - individuals under the age of 16.
|
|The government began its investigation of Orphan in 2005, when former
|Orphan saleswoman Shelley Lauterbach filed a qui tam suit against the
|company.  During the course of the investigation, Caronia was recorded
|on two occasions discussing off-label uses of Xyrem.  On both occasions,
|Caronia was recorded speaking alongside Dr. Peter Gleason, a doctor
|that Caronia had engaged to participate in "speaker programs" intended
|to educate other physicians about Xyrem.  Caronia and Dr. Gleason
|discussed off-label uses for Xyrem with Dr. Jeffrey Charo, an undercover
|informant for the government.  In 2006, the government filed

Re: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Ken Steele]

Hi Joe:

One difficulty I have with evaluating your argument is that I 
don't know the specific details of your case.  This is not a call 
to reveal private details but it is difficult for me to plumb 
your benefit/danger ratios without details.


I think Mike P's point is that dealing with Big Pharma is like 
dealing with Walmart, an aggressive and well-financed 
organization with a clear goal.  Your point is that the entire 
world is not all like Walmart, or that there are good deals to be 
had at Walmart if you are a smart shopper.


Both seem plausible positions, but are we talking about canoes or 
cannolis?


Ken

PS - Sorry to all who must live with a Walmart analogy; it is my 
world and there is not a fresh cannoli to be purchased in Boone.


---
Kenneth M. Steele, Ph.D.  steel...@appstate.edu
Professor
Department of Psychology  http://www.psych.appstate.edu
Appalachian State University
Boone, NC 28608
USA
---


On 1/8/2013 4:47 PM, Horton, Joseph J. wrote:

Mike my point is that there is potential harm when the FDA
limits available treatments. Unless there is fraud involved, I
am all for open communication between pharmaceutical
companies, physicians and their patients.

I certainly appreciate the role of well-done clinical trials.
(Note my signature file.) In the case of the drug I take, the
patent protection expired decades ago. No clinical trials will
be done. The potential side effects are well known. I am
probably in more danger from taking low dose aspirin daily. I
have to make decisions with less than perfect information
every day. I support letting information freely flow so people
can evaluate the evidence and make the most informed decisions
possible.

Have a lovely evening, Joe

Joseph J. Horton, Ph. D. Box 3077 Grove City College Grove
City, PA 16127

724-458-2004 jjhor...@gcc.edu

In God we trust. All others must bring data.

-Original Message- From: Mike Palij
[mailto:m...@nyu.edu] Sent: Tuesday, January 08, 2013 1:33 PM
To: Teaching in the Psychological Sciences (TIPS) Cc: Michael
Palij Subject: RE: [tips] Failure of Critical Thinking: When
Advertising Trumps "Truth"

On Tue, 08 Jan 2013 08:59:25 -0800, Joseph J. Horton wrote:

I am not particularly disturbed by this ruling depending
upon just what claims are being made. If it is clear the
claim is based on a collection of anecdotes rather than
empirical study informing physicians that others have found
a drug useful seems fine.


I suggest reading the following blog entry from a legal firm
that maintains the blog as a source of information on legal
issues involving the FDA:
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2012/12/a-deep-dive-into-the-second-circuits-caronia-decision-potential-next-steps-and-potential-enforcement.html



I say this as one who regularly takes a drug for off label
use.


I am not sure how this is relevant since mere personal
experiences do not constitute data, only anecdote (at best a
case study if done systematically but case studies are not
scientific studies).  That being said, I too have had
conditions where there was no established treatment and have
received numerous drugs off-label, none of which worked (you
don't know how much I hoped for a good placebo effect).  A
major problem with off-label drug treatment are the
side-effects which can be significant.  Sometimes one thinks
one is taking a step forward but winds up taking two steps
back.


It is a generic drug and has been for a very long time. Thus
it costs very little. No one would invest the time and money
to conduct a clinical trial for my issue. Yet the drug has
dramatically improved my quality of life. Were the FDA to
take away my physician's ability to prescribe it for me, I
would be quite disappointed.


With all sincerity, I am glad that the drug has done you good
but I hope you realize that if it is being used off-label: (a)
there is no empirical research evidence that the drug is the
cause of the improvement (that is one of the major problems
with using a drug in an off-label manner though there may be
various crappy "open label" studies -- studies where
participants and researchers know who is receiving the drug,
possibly with no placebo control) and (b) even if the "Caronia
case" goes in favor of the FDA on appeal, your doctor can
still treat you with the off label drug because the FDA's
focus is on the marketing of the drug.

Below I quote from the legal blog I cite above but I give
warning that the quote is long.  It does, however, provide
much significant context:

NOTE: the FDA prosecutes off label marketing as a violation
of interstate commerce law; see the blog for details |On
November 30, 2009, a jury found Alfred Caronia guilty of
misdemeanor |conspiracy to introduce misbranded drugs into
interstate commerce.  His |conviction was based on off-label
statements he made

RE: [tips] BREAKING NEWS: Professors less stressful

[Zasloff, Lee]

They obviously didn't survey adjuncts.



R. Lee Zasloff, PhD
Adjunct Instructor, Psychology
American River College
Sacramento, CA
http://www.wix.com/rlzasloff/animal-connections

From: michael sylvester [msylves...@copper.net]
Sent: Tuesday, January 08, 2013 12:54 PM
To: Teaching in the Psychological Sciences (TIPS)
Subject: [tips] BREAKING NEWS: Professors less stressful










CNN is reporting that the least stressful job is that of a University professor 
and next is a seamstress.
I am not sure if this applies to the department chairperson.
michael


---

You are currently subscribed to tips as: 
zasl...@arc.losrios.edu.

To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=563788.826e2126ca226db4aa4ffe75f22f5c88&n=T&l=tips&o=22769

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to 
leave-22769-563788.826e2126ca226db4aa4ffe75f22f5...@fsulist.frostburg.edu







---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22776
or send a blank email to 
leave-22776-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

RE: [tips] BREAKING NEWS: Professors less stressful

[Tim Shearon]

All
I find it hard to believe as well. They must have done the survey over break. 
But I concur that they did not survey department heads! :) Of course another 
explanation might be that we professors don't handle stress well at all so our 
small stress seems large to us! (I looked on CNN and the only source I saw said 
College Prof was #3. I didn't see seamstress on the list though so it must be a 
different survey).
Tim

From: José Ferreira Alves [mailto:al...@psi.uminho.pt]
Sent: Tuesday, January 08, 2013 1:57 PM
To: Teaching in the Psychological Sciences (TIPS)
Subject: RE: [tips] BREAKING NEWS: Professors less stressful










I can't believe in that!!
Seems to me that we are within the most stressful and challenging jobs, 
although also with good rewards
Jose









CNN is reporting that the least stressful job is that of a University professor 
and next is a seamstress.
I am not sure if this applies to the department chairperson.
michael


---

You are currently subscribed to tips as: 
al...@psi.uminho.pt.

To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13079.37464550bba7c9b4601a21fd9decb43c&n=T&l=tips&o=22769

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to 
leave-22769-13079.37464550bba7c9b4601a21fd9decb...@fsulist.frostburg.edu








---

You are currently subscribed to tips as: 
tshea...@collegeofidaho.edu.

To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13545.bae00fb8b4115786ba5dbbb67b9b177a&n=T&l=tips&o=22770

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to 
leave-22770-13545.bae00fb8b4115786ba5dbbb67b9b1...@fsulist.frostburg.edu







---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22777
or send a blank email to 
leave-22777-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

[tips] "MUST" reading in human memory

[Annette Taylor]

I am putting together a bibliography list of what might be considered "must" 
reading for average ability readers, regarding human memory. I am including 
works like Rumelhart & McClelland's work on Parallel distributed processing, 
but prefer things like Allman's Apprentices of wonder: Inside the neural 
network revolution, by comparision.

If anyone has suggestions I would be most appreciative. Please reply off list 
and I will generate a complete list for everyone in a couple of days.

Thank you.

Annette

Annette Kujawski Taylor, Ph. D.
Professor, Psychological Sciences
University of San Diego
5998 Alcala Park
San Diego, CA 92110
tay...@sandiego.edu
---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22778
or send a blank email to 
leave-22778-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

Don't Forget The Cannoli (was Re: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Mike Palij]

I don't understand why but I'm starting to feel like I'm writing in
Portuguese or something because some key points keep getting
missed.  Let me refer interested readers to the pro-business
"Business Insider" which has a short article on this case and
praises the decision to let Big Pharma market a drug for the
treatment of any condition whatsoever regardless of whether
it has been shown to be an effective treatment for it; see:
http://www.businessinsider.com/alfred-caronia-legal-victory-2012-12

Here is a critical bit:
|It's always been perfectly legal for doctors to prescribe drugs
|for uses that the FDA hasn't approved. However, federal law
|has barred drug companies from promoting medicine for anything
|other than its officially approved use.

So, even if the decision is reversed on appeal, this does not mean
that the "black helicopters" of FDA will swoop down in the dead of
night to people's homes to take their off-labeled used drugs.  Even
if reversed, a doctor will still be able to prescribe drugs for off-label
use even though (a) there may be no scientific evidence that such
usage produces a benefit outside of a placebo effect and (b) Big
Pharma may promote such practice because it may keep a drug
profitable.

So, the failure of critical thinking is manifested in the lack of 
realization
that using a drug off-label has no real empirical basis outside of a 
possible
placebo effect.  Is it possible that some off-label use will lead to 
research

that actually shows the drug to be effective? Yes.  Is it also possible that
research will show the off-label drug is no more effective than placebo?

Yes.  Which case is true in reality?  No one knows until the proper
research is done.  Nonetheless, some people might think that they need
expensive placebos effects.

Finally, a legal point that I want to make perfectly clear:

THE FDA PROSECUTES THE ***MARKETING OF DRUGS***
AS TREATMENTS FOR ILLNESSES THAT THEY HAVE NOT BEEN
SHOWN TO BE EFFECTIVE FOR.

That is what Caronia and his colleagues were charged with and most found
guilty for except until the court made its weird first amendment 
interpretation.


So, if one is using generic or brand name drugs off-label, they can continue
to do so JUST REMEMBER THAT BEING OFF-LABEL MEANS THAT
THERE IS NO EVIDENCE THAT THEY ARE EFFECTIVE FOR WHATEVER
IS BEING TREATED.

Remember: think.

And now we've gotten Walmart and cannoli into the mix!  Either stop the
insanity or pass me a cannoli.

-Mike Palij
New York University
m...@nyu.edu

P.S. The singular form of cannoli is cannolo but Americans treat cannoli
as singular and wind up using cannolis for the plural.  Since I'm not one
of those anal-retentive APA style perfectionists, it don't make no never
mind to me.  For more on Cannoli, see:
http://en.wikipedia.org/wiki/Cannoli

Mmmm, cannoli! ;-)

-  Original Message  ---
On Tue, 08 Jan 2013 14:53:16 -0800, Ken Steele wrote:

Hi Joe:

One difficulty I have with evaluating your argument is that I
don't know the specific details of your case. This is not a
call to reveal private details but it is difficult for me to plumb
your benefit/danger ratios without details.

I think Mike P's point is that dealing with Big Pharma is like
dealing with Walmart, an aggressive and well-financed
organization with a clear goal. Your point is that the entire
world is not all like Walmart, or that there are good deals
to be had at Walmart if you are a smart shopper.

Both seem plausible positions, but are we talking about canoes
or cannolis?
Ken

PS - Sorry to all who must live with a Walmart analogy; it is
my world and there is not a fresh cannoli to be purchased in Boone. 



---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22779
or send a blank email to 
leave-22779-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

[tips] Why some adjuncts are stressed?

[michael sylvester]

Ali Vouchi of CNN reported the data.He said that the average Prof  salary is 
about 60,000 and can extend to 200,000'
Seamstress come in second not because of money but seamstressing can be a 
creative activity

WHY SOME ADJUNCTS ARE STRESSED
-they work for peanuts
-they are not sure if their classes will make
-they try hard to get good teahing evaluations by giving high grades to students
-they are omitted from the department christmas party
-they do not get reimburse for mileage
-Health insurance may not cover their nervous breakdown
Some adjunts are never in their offices
Some adjuncts are teaching at five different institutions the same day
They are more likely to teach touchy feely classes like Human Sexuality and 
Death and dying
Some adjuncts will volunteer for anything
michael
  - Original Message - 
  From: Zasloff, Lee 
  To: Teaching in the Psychological Sciences (TIPS) 
  Sent: Tuesday, January 08, 2013 3:21 PM
  Subject: RE: [tips] BREAKING NEWS: Professors less stressful














  They obviously didn't survey adjuncts.



  R. Lee Zasloff, PhD
  Adjunct Instructor, Psychology
  American River College
  Sacramento, CA
  http://www.wix.com/rlzasloff/animal-connections

--

  From: michael sylvester [msylves...@copper.net]
  Sent: Tuesday, January 08, 2013 12:54 PM
  To: Teaching in the Psychological Sciences (TIPS)
  Subject: [tips] BREAKING NEWS: Professors less stressful














  CNN is reporting that the least stressful job is that of a University 
professor and next is a seamstress.
  I am not sure if this applies to the department chairperson.
michael


  ---

  You are currently subscribed to tips as: zasl...@arc.losrios.edu.

  To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=563788.826e2126ca226db4aa4ffe75f22f5c88&n=T&l=tips&o=22769

  (It may be necessary to cut and paste the above URL if the line is broken)

  or send a blank email to 
leave-22769-563788.826e2126ca226db4aa4ffe75f22f5...@fsulist.frostburg.edu











  ---

  You are currently subscribed to tips as: msylves...@copper.net.

  To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13424.eb17e1c03643c971ab35c22d86587541&n=T&l=tips&o=22776

  (It may be necessary to cut and paste the above URL if the line is broken)

  or send a blank email to 
leave-22776-13424.eb17e1c03643c971ab35c22d86587...@fsulist.frostburg.edu









---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22781
or send a blank email to 
leave-22781-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

Re: Don't Forget The Cannoli (was Re: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Paul Brandon]

First of all -- in the words of Obiwan Cannoli:  NO ONE has just one cannola.
   And more seriously
First, is this legal thinking or medical reasoning?
Second, is this a weakness on the part of "Business Insider", or on the part of 
their readers and consumers in general?
And third, this is assuming that the main motivation of the BioMed industry is 
curing disease.

On Jan 8, 2013, at 5:54 PM, Mike Palij wrote:

> I don't understand why but I'm starting to feel like I'm writing in
> Portuguese or something because some key points keep getting
> missed.  Let me refer interested readers to the pro-business
> "Business Insider" which has a short article on this case and
> praises the decision to let Big Pharma market a drug for the
> treatment of any condition whatsoever regardless of whether
> it has been shown to be an effective treatment for it; see:
> http://www.businessinsider.com/alfred-caronia-legal-victory-2012-12
> 
> Here is a critical bit:
> |It's always been perfectly legal for doctors to prescribe drugs
> |for uses that the FDA hasn't approved. However, federal law
> |has barred drug companies from promoting medicine for anything
> |other than its officially approved use.
> 
> So, even if the decision is reversed on appeal, this does not mean
> that the "black helicopters" of FDA will swoop down in the dead of
> night to people's homes to take their off-labeled used drugs.  Even
> if reversed, a doctor will still be able to prescribe drugs for off-label
> use even though (a) there may be no scientific evidence that such
> usage produces a benefit outside of a placebo effect and (b) Big
> Pharma may promote such practice because it may keep a drug
> profitable.
> 
> So, the failure of critical thinking is manifested in the lack of realization
> that using a drug off-label has no real empirical basis outside of a possible
> placebo effect.  Is it possible that some off-label use will lead to research
> that actually shows the drug to be effective? Yes.  Is it also possible that
> research will show the off-label drug is no more effective than placebo?
> 
> Yes.  Which case is true in reality?  No one knows until the proper
> research is done.  Nonetheless, some people might think that they need
> expensive placebos effects.
> 
> Finally, a legal point that I want to make perfectly clear:
> 
> THE FDA PROSECUTES THE ***MARKETING OF DRUGS***
> AS TREATMENTS FOR ILLNESSES THAT THEY HAVE NOT BEEN
> SHOWN TO BE EFFECTIVE FOR.
> 
> That is what Caronia and his colleagues were charged with and most found
> guilty for except until the court made its weird first amendment 
> interpretation.
> 
> So, if one is using generic or brand name drugs off-label, they can continue
> to do so JUST REMEMBER THAT BEING OFF-LABEL MEANS THAT
> THERE IS NO EVIDENCE THAT THEY ARE EFFECTIVE FOR WHATEVER
> IS BEING TREATED.
> 
> Remember: think.
> 
> And now we've gotten Walmart and cannoli into the mix!  Either stop the
> insanity or pass me a cannoli.
> 
> -Mike Palij
> New York University
> m...@nyu.edu
> 
> P.S. The singular form of cannoli is cannolo but Americans treat cannoli
> as singular and wind up using cannolis for the plural.  Since I'm not one
> of those anal-retentive APA style perfectionists, it don't make no never
> mind to me.  For more on Cannoli, see:
> http://en.wikipedia.org/wiki/Cannoli
> 
> Mmmm, cannoli! ;-)
> 
> -  Original Message  ---
> On Tue, 08 Jan 2013 14:53:16 -0800, Ken Steele wrote:
>> Hi Joe:
>> 
>> One difficulty I have with evaluating your argument is that I
>> don't know the specific details of your case. This is not a
>> call to reveal private details but it is difficult for me to plumb
>> your benefit/danger ratios without details.
>> 
>> I think Mike P's point is that dealing with Big Pharma is like
>> dealing with Walmart, an aggressive and well-financed
>> organization with a clear goal. Your point is that the entire
>> world is not all like Walmart, or that there are good deals
>> to be had at Walmart if you are a smart shopper.
>> 
>> Both seem plausible positions, but are we talking about canoes
>> or cannolis?
>> Ken
>> 
>> PS - Sorry to all who must live with a Walmart analogy; it is
>> my world and there is not a fresh cannoli to be purchased in Boone. 
> 
> 
> ---
> You are currently subscribed to tips as: pkbra...@hickorytech.net.
> To unsubscribe click here: 
> http://fsulist.frostburg.edu/u?id=13438.3b5166ef147b143fedd04b1c4a64900b&n=T&l=tips&o=22779
> or send a blank email to 
> leave-22779-13438.3b5166ef147b143fedd04b1c4a649...@fsulist.frostburg.edu

Paul Brandon
Emeritus Professor of Psychology
Minnesota State University, Mankato
pkbra...@hickorytech.net




---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22782
or send a blank email to 
leave-22782-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

Re: Don't Forget The Cannoli (was Re: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Ken Steele]

Sent from my iPad

On Jan 8, 2013, at 6:54 PM, Mike P wrote 
> 

> -Mike Palij
> New York University
> m...@nyu.edu
> 
> P.S. The singular form of cannoli is cannolo but Americans treat cannoli
> as singular and wind up using cannolis for the plural.  Since I'm not one
> of those anal-retentive APA style perfectionists, it don't make no never
> mind to me.  For more on Cannoli, see:
> http://en.wikipedia.org/wiki/Cannoli
> 

Mea culpa. Mea maxima culpa. My Latin teacher would be so ashamed of me.

Ken








---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22783
or send a blank email to 
leave-22783-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

RE: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Horton, Joseph J.]

Hello Ken: I live in a small town and have a love-hate relationship with 
Wal-Mart. I will try a different comparison. I would like my physician to be 
able to be a like the Food Network's Alton Brown. For those who are not 
familiar with Mr. Brown, he believes that every device in his kitchen should be 
able to perform multiple tasks. He will do things like cut cakes with saw 
blades, or turn a military surplus footlocker into a meat smoker. Now the 
people at the hardware store and the cooking supply store have products to 
sell. Some of the people at the store will try to sell things that we do not 
need or could be harmful if misused. I am willing to let Alton talk with the 
people at the store about alternative uses for their products. Alton and I may 
then consider how best to prepare dinner. If there is fraud involved, I want 
the people engaging in it prosecuted.

I do understand that the FDA will not be coming in their black helicopters to 
keep Alton from giving me a saw for cutting cakes. I do not want the black 
helicopters showing up at the hardware store on the assumption that any 
non-traditional use of saws should not be discussed between sales people and 
cooks.

Joe

Joseph J. Horton, Ph. D.
Box 3077
Grove City College
Grove City, PA 16127
724-458-2004
jjhor...@gcc.edu

In God we trust, all others must bring data.


From: Ken Steele [steel...@appstate.edu]
Sent: Tuesday, January 08, 2013 5:52 PM
To: Teaching in the Psychological Sciences (TIPS)
Subject: Re: [tips] Failure of Critical Thinking: When Advertising Trumps 
"Truth"

Hi Joe:

One difficulty I have with evaluating your argument is that I
don't know the specific details of your case.  This is not a call
to reveal private details but it is difficult for me to plumb
your benefit/danger ratios without details.

I think Mike P's point is that dealing with Big Pharma is like
dealing with Walmart, an aggressive and well-financed
organization with a clear goal.  Your point is that the entire
world is not all like Walmart, or that there are good deals to be
had at Walmart if you are a smart shopper.

Both seem plausible positions, but are we talking about canoes or
cannolis?

Ken

PS - Sorry to all who must live with a Walmart analogy; it is my
world and there is not a fresh cannoli to be purchased in Boone.

---
Kenneth M. Steele, Ph.D.  steel...@appstate.edu
Professor
Department of Psychology  http://www.psych.appstate.edu
Appalachian State University
Boone, NC 28608
USA
---


On 1/8/2013 4:47 PM, Horton, Joseph J. wrote:
> Mike my point is that there is potential harm when the FDA
> limits available treatments. Unless there is fraud involved, I
> am all for open communication between pharmaceutical
> companies, physicians and their patients.
>
> I certainly appreciate the role of well-done clinical trials.
> (Note my signature file.) In the case of the drug I take, the
> patent protection expired decades ago. No clinical trials will
> be done. The potential side effects are well known. I am
> probably in more danger from taking low dose aspirin daily. I
> have to make decisions with less than perfect information
> every day. I support letting information freely flow so people
> can evaluate the evidence and make the most informed decisions
> possible.
>
> Have a lovely evening, Joe
>
> Joseph J. Horton, Ph. D. Box 3077 Grove City College Grove
> City, PA 16127
>
> 724-458-2004 jjhor...@gcc.edu
>
> In God we trust. All others must bring data.
>
> -Original Message- From: Mike Palij
> [mailto:m...@nyu.edu] Sent: Tuesday, January 08, 2013 1:33 PM
> To: Teaching in the Psychological Sciences (TIPS) Cc: Michael
> Palij Subject: RE: [tips] Failure of Critical Thinking: When
> Advertising Trumps "Truth"
>
> On Tue, 08 Jan 2013 08:59:25 -0800, Joseph J. Horton wrote:
>> I am not particularly disturbed by this ruling depending
>> upon just what claims are being made. If it is clear the
>> claim is based on a collection of anecdotes rather than
>> empirical study informing physicians that others have found
>> a drug useful seems fine.
>
> I suggest reading the following blog entry from a legal firm
> that maintains the blog as a source of information on legal
> issues involving the FDA:
> http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2012/12/a-deep-dive-into-the-second-circuits-caronia-decision-potential-next-steps-and-potential-enforcement.html
>
>
>> I say this as one who regularly takes a drug for off label
>> use.
>
> I am not sure how this is relevant since mere personal
> experiences do not constitute data, only anecdote (at best a
> case study if done systematically but case studies are not
> scientific studies).  That being said, I too have had
> conditions where there was no established treatment and have
> received numerous drugs off-label, 

Re: [tips] Failure of Critical Thinking: When Advertising Trumps "Truth"

[Paul Brandon]

Alton Brown is less likely to kill people by recommending unproven procedures.
False analogy!

On Jan 8, 2013, at 8:11 PM, Horton, Joseph J. wrote:

> Hello Ken: I live in a small town and have a love-hate relationship with 
> Wal-Mart. I will try a different comparison. I would like my physician to be 
> able to be a like the Food Network's Alton Brown. For those who are not 
> familiar with Mr. Brown, he believes that every device in his kitchen should 
> be able to perform multiple tasks. He will do things like cut cakes with saw 
> blades, or turn a military surplus footlocker into a meat smoker. Now the 
> people at the hardware store and the cooking supply store have products to 
> sell. Some of the people at the store will try to sell things that we do not 
> need or could be harmful if misused. I am willing to let Alton talk with the 
> people at the store about alternative uses for their products. Alton and I 
> may then consider how best to prepare dinner. If there is fraud involved, I 
> want the people engaging in it prosecuted.
> 
> I do understand that the FDA will not be coming in their black helicopters to 
> keep Alton from giving me a saw for cutting cakes. I do not want the black 
> helicopters showing up at the hardware store on the assumption that any 
> non-traditional use of saws should not be discussed between sales people and 
> cooks.
> 
> Joe
> 
> Joseph J. Horton, Ph. D.
> Box 3077
> Grove City College
> Grove City, PA 16127
> 724-458-2004
> jjhor...@gcc.edu
> 
> In God we trust, all others must bring data.
> 
> 
> From: Ken Steele [steel...@appstate.edu]
> Sent: Tuesday, January 08, 2013 5:52 PM
> To: Teaching in the Psychological Sciences (TIPS)
> Subject: Re: [tips] Failure of Critical Thinking: When Advertising Trumps 
> "Truth"
> 
> Hi Joe:
> 
> One difficulty I have with evaluating your argument is that I
> don't know the specific details of your case.  This is not a call
> to reveal private details but it is difficult for me to plumb
> your benefit/danger ratios without details.
> 
> I think Mike P's point is that dealing with Big Pharma is like
> dealing with Walmart, an aggressive and well-financed
> organization with a clear goal.  Your point is that the entire
> world is not all like Walmart, or that there are good deals to be
> had at Walmart if you are a smart shopper.
> 
> Both seem plausible positions, but are we talking about canoes or
> cannolis?
> 
> Ken
> 
> PS - Sorry to all who must live with a Walmart analogy; it is my
> world and there is not a fresh cannoli to be purchased in Boone.
> 
> ---
> Kenneth M. Steele, Ph.D.  steel...@appstate.edu
> Professor
> Department of Psychology  http://www.psych.appstate.edu
> Appalachian State University
> Boone, NC 28608
> USA
> ---
> 
> 
> On 1/8/2013 4:47 PM, Horton, Joseph J. wrote:
>> Mike my point is that there is potential harm when the FDA
>> limits available treatments. Unless there is fraud involved, I
>> am all for open communication between pharmaceutical
>> companies, physicians and their patients.
>> 
>> I certainly appreciate the role of well-done clinical trials.
>> (Note my signature file.) In the case of the drug I take, the
>> patent protection expired decades ago. No clinical trials will
>> be done. The potential side effects are well known. I am
>> probably in more danger from taking low dose aspirin daily. I
>> have to make decisions with less than perfect information
>> every day. I support letting information freely flow so people
>> can evaluate the evidence and make the most informed decisions
>> possible.
>> 
>> Have a lovely evening, Joe
>> 
>> Joseph J. Horton, Ph. D. Box 3077 Grove City College Grove
>> City, PA 16127
>> 
>> 724-458-2004 jjhor...@gcc.edu
>> 
>> In God we trust. All others must bring data.
>> 
>> -Original Message- From: Mike Palij
>> [mailto:m...@nyu.edu] Sent: Tuesday, January 08, 2013 1:33 PM
>> To: Teaching in the Psychological Sciences (TIPS) Cc: Michael
>> Palij Subject: RE: [tips] Failure of Critical Thinking: When
>> Advertising Trumps "Truth"
>> 
>> On Tue, 08 Jan 2013 08:59:25 -0800, Joseph J. Horton wrote:
>>> I am not particularly disturbed by this ruling depending
>>> upon just what claims are being made. If it is clear the
>>> claim is based on a collection of anecdotes rather than
>>> empirical study informing physicians that others have found
>>> a drug useful seems fine.
>> 
>> I suggest reading the following blog entry from a legal firm
>> that maintains the blog as a source of information on legal
>> issues involving the FDA:
>> http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2012/12/a-deep-dive-into-the-second-circuits-caronia-decision-potential-next-steps-and-potential-enforcement.html
>> 
>> 
>>> I say this as one who regularly takes a drug for off label
>>> us

Re: [tips] BREAKING NEWS: Professors less stressful

[drnanjo]

I agree that they did not survey adjuncts.
Most are stressed to the limit in this economy.
Especially in California...

Nancy Melucci
Long Beach City College


-Original Message-
From: Tim Shearon 
To: Teaching in the Psychological Sciences (TIPS) 
Sent: Tue, Jan 8, 2013 3:26 pm
Subject: RE: [tips] BREAKING NEWS: Professors less stressful



 


 


 


All
I find it hard to believe as well. They must have done the survey over break. 
But I concur that they did not survey department heads! J Of course another 
explanation might be that we professors don’t handle stress well at all so our 
small stress seems large to us! (I looked on CNN and the only source I saw said 
College Prof was #3. I didn’t see seamstress on the list though so it must be a 
different survey).
Tim
 

From: José Ferreira Alves [mailto:al...@psi.uminho.pt] 
Sent: Tuesday, January 08, 2013 1:57 PM
To: Teaching in the Psychological Sciences (TIPS)
Subject: RE: [tips] BREAKING NEWS: Professors less stressful

 
 
 
 
 
 
 
I can’t believe in that!!
Seems to me that we are within the most stressful and challenging jobs, 
although also with good rewards
Jose
 
 
 
 
 
 

CNN is reporting that the least stressful job is that of a University professor 
and next is a seamstress.

I am not sure if this applies to the department chairperson.


michael

 
---
You are currently subscribed to tips as: al...@psi.uminho.pt.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13079.37464550bba7c9b4601a21fd9decb43c&n=T&l=tips&o=22769
(It may be necessary to cut and paste the above URL if the line is broken)
or send a blank email to 
leave-22769-13079.37464550bba7c9b4601a21fd9decb...@fsulist.frostburg.edu
 
 
 
 
 
---
You are currently subscribed to tips as: tshea...@collegeofidaho.edu.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13545.bae00fb8b4115786ba5dbbb67b9b177a&n=T&l=tips&o=22770
(It may be necessary to cut and paste the above URL if the line is broken)
or send a blank email to 
leave-22770-13545.bae00fb8b4115786ba5dbbb67b9b1...@fsulist.frostburg.edu
 
 
 
 


---

You are currently subscribed to tips as: drna...@aol.com.

To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=12993.aba36cc3760e0b1c6a655f019a68b878&n=T&l=tips&o=22777

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to 
leave-22777-12993.aba36cc3760e0b1c6a655f019a68b...@fsulist.frostburg.edu


 


 

 

---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=22792
or send a blank email to 
leave-22792-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu